Pursley James 4

What Happened
James Pursley, President of Hinge Health (HNGE), sold a total of 15,000 shares in open-market transactions on February 23, 2026 for aggregate proceeds of approximately $589,984. The sales were reported as three dispositions: 7,874 shares at an average around $38.76 ($305,159), 6,818 shares at an average around $39.95 ($272,363), and 308 shares at about $40.46 ($12,462). These were sales (not purchases or option exercises) and were effected under a pre-established trading plan.

Key Details

• Transaction date: February 23, 2026; Form 4 filed February 24, 2026 (timely filing).
• Shares sold: 7,874; 6,818; 308 — total 15,000 shares.
• Proceeds: $305,159; $272,363; $12,462 — total ≈ $589,984.
• Price details / footnotes:
  • F1: Sales executed pursuant to a Rule 10b5-1 trading plan adopted June 12, 2025.
  • F2–F4: Weighted-average prices reported for each line; reported lowest/highest sale prices in the ranges were $38.435–$39.41, $39.45–$40.44, and $40.45–$40.46 respectively. The filer offers to provide per-price share counts on request.
• Shares owned after transaction: Not specified in the provided filing.

Context

• Sales under a 10b5-1 plan are typically pre-scheduled and are common for insiders to diversify or meet liquidity needs; they are not necessarily an indicator of new negative sentiment.
• This filing reports outright sales (code S); no option exercises, grants, or gifts are involved.
• For retail investors, purchases are usually more informative than routine sales; note these were disposals under a pre-set plan.